English
Insider transactions
EDGARACURX PHARMACEUTICALS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–8 of 8
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-20 Filed 2026-04-22 | DELUCCIA ROBERT J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 37,100 | 0 | — | 37,100 | Direct (D) | No | F1
| Open filing 0001104659-26-046836 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | HARRISON THOMAS L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,150 | 0 | — | 2,150 | Direct (D) | No | F1
| Open filing 0001104659-26-046840 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | LUCI DAVID P Director · Officer: President and CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 37,100 | 0 | — | 37,100 | Direct (D) | No | F1
| Open filing 0001104659-26-046835 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Donohue James J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,150 | 0 | — | 2,150 | Direct (D) | No | F1
| Open filing 0001104659-26-046842 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Sailer Carl Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,150 | 0 | — | 2,150 | Direct (D) | No | F1
| Open filing 0001104659-26-046846 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Shawah Robert G. Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,900 | 0 | — | 25,900 | Direct (D) | No | F1
| Open filing 0001104659-26-046833 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | Scodari Joseph C Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,150 | 0 | — | 2,150 | Direct (D) | No | F1
| Open filing 0001104659-26-046837 Read from the filing’s XML Dispute this row |
| 2026-04-20 Filed 2026-04-22 | DEAN JACK H Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,150 | 0 | — | 2,150 | Direct (D) | No | F1
| Open filing 0001104659-26-046844 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Armistice Capital, LLC Common Stock | 4.99 | 83,233.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-25-005168 Dispute this row |
| Steven Boyd Common Stock | 4.99 | 83,233.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-25-005168 Dispute this row |
| Armistice Capital, LLC Common Stock | 8.70 | 2,917,975.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G | Open filing 0001172661-25-003563 Dispute this row |
| Steven Boyd Common Stock | 8.70 | 2,917,975.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G | Open filing 0001172661-25-003563 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 103,592 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,124 |
Filings made before the SEC required XML are listed, not extracted.